Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11577)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 13, 2018 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tecalco-Cruz AC, Ramírez-Jarquín JO. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer. World J Clin Oncol 2018; 9(4): 60-70 [PMID: 30148069 DOI: 10.5306/wjco.v9.i4.60] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v9/i4/60.htm |
| Number | Citing Articles |
| 1 |
Sadia Afrin, Malak El Sabeh, Md Soriful Islam, Mariko Miyashita-Ishiwata, Minnie Malik, William H. Catherino, Askar M. Akimzhanov, Darren Boehning, Qiwei Yang, Ayman Al-Hendy, James H. Segars, Mostafa A. Borahay. Simvastatin modulates estrogen signaling in uterine leiomyoma via regulating receptor palmitoylation, trafficking and degradation. Pharmacological Research 2021; 172: 105856 doi: 10.1016/j.phrs.2021.105856
|
| 2 |
Sarah A. Jeffreys, Branka Powter, Bavanthi Balakrishnar, Kelly Mok, Patsy Soon, André Franken, Hans Neubauer, Paul de Souza, Therese M. Becker. Endocrine Resistance in Breast Cancer: The Role of Estrogen Receptor Stability. Cells 2020; 9(9): 2077 doi: 10.3390/cells9092077
|
| 3 |
Arunita Patra, Arghya Adhikary, Swatilekha Ghosh. The unfolded protein response (UPR) pathway: the unsung hero in breast cancer management. Apoptosis 2023; 28(3-4): 263 doi: 10.1007/s10495-022-01803-3
|
| 4 |
Min Xue, Kai Zhang, Kun Mu, Juntao Xu, Huijie Yang, Yun Liu, Beibei Wang, Zhonghao Wang, Zhongbo Li, Qiong Kong, Xiumin Li, Hui Wang, Jian Zhu, Ting Zhuang. Regulation of estrogen signaling and breast cancer proliferation by an ubiquitin ligase TRIM56. Oncogenesis 2019; 8(5) doi: 10.1038/s41389-019-0139-x
|
| 5 |
Jing-Wen Bai, Min Wei, Ji-Wei Li, Guo-Jun Zhang. Notch Signaling Pathway and Endocrine Resistance in Breast Cancer. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00924
|
| 6 |
Angeles C Tecalco-Cruz, María Jazmin Abraham-Juárez, Helena Solleiro-Villavicencio, Josué Orlando Ramírez-Jarquín. TRIM25: A central factor in breast cancer. World Journal of Clinical Oncology 2021; 12(8): 646-655 doi: 10.5306/wjco.v12.i8.646
|
| 7 |
Takahiro Masaki, Makoto Habara, Yuki Sato, Takahiro Goshima, Keisuke Maeda, Shunsuke Hanaki, Midori Shimada. Calcineurin regulates the stability and activity of estrogen receptor α. Proceedings of the National Academy of Sciences 2021; 118(44) doi: 10.1073/pnas.2114258118
|
| 8 |
Xianguang Deng, Juan Wang, Chenyi Lu, Yao Zhou, Lele Shen, Anqi Ge, Hongqiao Fan, Lifang Liu. Updating the therapeutic role of ginsenosides in breast cancer: a bibliometrics study to an in-depth review. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1226629
|
| 9 |
Angeles C. Tecalco-Cruz, Josué Orlando Ramírez-Jarquín, Marina Macías-Silva, Marcela Sosa-Garrocho, César López-Camarillo. Breast Cancer. 2022; : 179 doi: 10.36255/exon-publications-breast-cancer-protacs
|
| 10 |
久程 周. Advances in the Study of Adverse Reactions after Endocrine Therapy for Breast Cancer. Advances in Clinical Medicine 2023; 13(11): 17275 doi: 10.12677/ACM.2023.13112420
|
| 11 |
Angeles C. Tecalco-Cruz, Josué O. Ramírez-Jarquín, Eduardo Cruz-Ramos. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells. Current Drug Targets 2019; 20(6): 690 doi: 10.2174/1389450119666181015114041
|
| 12 |
Guy Leclercq. Pathological Maintenance and Evolution of Breast Cancer: The Convergence of Irreversible Biological Actions of ER Alpha. Endocrines 2020; 2(1): 1 doi: 10.3390/endocrines2010001
|
| 13 |
Anca-Narcisa Neagu, Claudiu-Laurentiu Josan, Taniya M. Jayaweera, Hailey Morrissiey, Kaya R. Johnson, Costel C. Darie. Bio-Pathological Functions of Posttranslational Modifications of Histological Biomarkers in Breast Cancer. Molecules 2024; 29(17): 4156 doi: 10.3390/molecules29174156
|
| 14 |
Antonio Strillacci, Pasquale Sansone, Vinagolu K. Rajasekhar, Mesruh Turkekul, Vitaly Boyko, Fanli Meng, Brian Houck-Loomis, David Brown, Michael F. Berger, Ronald C. Hendrickson, Qing Chang, Elisa de Stanchina, Fresia Pareja, Jorge S. Reis-Filho, Ramya Segu Rajappachetty, Isabella Del Priore, Bo Liu, Yanyan Cai, Alex Penson, Chiara Mastroleo, Marjan Berishaj, Francesca Borsetti, Enzo Spisni, David Lyden, Sarat Chandarlapaty, Jacqueline Bromberg. ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance. npj Breast Cancer 2022; 8(1) doi: 10.1038/s41523-022-00470-6
|
| 15 |
Sreeja Sreekumar, Kevin M Levine, Matthew J Sikora, Jian Chen, Nilgun Tasdemir, Dorothy Carter, David J Dabbs, Carolin Meier, Ahmed Basudan, David Boone, Priscilla F McAuliffe, Rachel C Jankowitz, Adrian V Lee, Jennifer M Atkinson, Steffi Oesterreich. Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast Carcinoma. Endocrinology 2020; 161(9) doi: 10.1210/endocr/bqaa109
|